Genome-Wide Association Study of MKI67 Expression and its Clinical Implications in HBV-Related Hepatocellular Carcinoma in Southern China
Background/Aims: Hepatocellular carcinoma (HCC) is a common malignant tumor with a high rate of recurrence. Immunohistochemical analysis of the marker of proliferation Ki-67 (MKI67) is used to assess proliferation activity of HCC The regulation of MKI67 expression remains unclear in HCC This study a...
Main Authors: | Cheng-kun Yang, Ting-dong Yu, Chuang-ye Han, Wei Qin, Xi-wen Liao, Long Yu, Xiao-guang Liu, Guang-zhi Zhu, Hao Su, Si-cong Lu, Zhi-wei Chen, Zhen Liu, Ke-tuan Huang, Zheng-tao Liu, Yu Liang, Jian-lu Huang, Zeng-nan Mo, Xue Qin, Lequn Li, Kai-yin Xiao, Min-hao Peng, Cheryl Ann Winkle, Stephen J. O'Brien, Tao Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/478963 |
Similar Items
-
Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
by: Yang C, et al.
Published: (2018-04-01) -
Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma
by: Shi-yi Wu, et al.
Published: (2021-11-01) -
Expression and Clinical Significance of MKI67 in Pancreatic Cancer
by: WANG Hu, et al.
Published: (2024-02-01) -
MKI67 as a potential diagnostic biomarker in pulmonary hypertension
by: Huiling Zhou, et al.
Published: (2022-11-01) -
A comprehensive analysis of the prognostic value, expression characteristics and immune correlation of MKI67 in cancers
by: Xiaolan Pan, et al.
Published: (2025-02-01)